Connect Biopharma Holdings (CNTB) Shares Outstanding (2020 - 2026)

Connect Biopharma Holdings (CNTB) has reported Shares Outstanding (Entity) for 7 consecutive years, with $56.5 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.16% year-over-year to $56.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.16% YoY) and the FY2025 annual result came in at $55.7 million, up 0.81% from the prior year.
• Shares Outstanding (Entity) climbed to $56.5 million in Q1 2026 per CNTB's latest filing, from $55.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for CNTB reached as high as $56.5 million in Q1 2026 and fell as low as $7.7 million in Q4 2022.
• A 5-year average of $41.3 million and a median of $55.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) slipped 5.87% — and 2026, when it climbed 2.16%.
• Year by year, Shares Outstanding (Entity) stood at $7.7 million in 2022, then grew by 1.56% to $7.9 million in 2023, then surged by 602.46% to $55.2 million in 2024, then gained by 0.81% to $55.7 million in 2025, then grew by 1.59% to $56.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $56.5 million, $55.7 million, and $55.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.